Jubilant Pharmova Limited (BOM: 530019)

India flag India · Delayed Price · Currency is INR
1,017.30
-13.10 (-1.27%)
At close: Sep 10, 2024
124.32%
Market Cap 163.28B
Revenue (ttm) 68.48B
Net Income (ttm) 5.53B
Shares Out 158.35M
EPS (ttm) 34.91
PE Ratio 29.54
Forward PE 23.90
Dividend 5.00 (0.49%)
Ex-Dividend Date Aug 2, 2024
Volume 40,834
Open 1,022.95
Previous Close 1,030.40
Day's Range 1,010.80 - 1,044.60
52-Week Range 319.30 - 1,047.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Jubilant Pharmova

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary ... [Read more]

Industry Pharmaceutical Preparations
Founded 1978
Employees 5,399
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530019
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.